Get the Stockscreener App
1.24
3.33%
0.04
After Hours:
1.23
-0.01
-0.81%
Painreform Ltd stock is traded at $1.24, with a volume of 48,281.
It is up +3.33% in the last 24 hours and down -11.43% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$1.20
Open:
$1.22
24h Volume:
48,281
Relative Volume:
0.02
Market Cap:
$2.50M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.1737
EPS:
-7.14
Net Cash Flow:
$-6.69M
1W Performance:
-4.98%
1M Performance:
-11.43%
6M Performance:
-48.76%
1Y Performance:
-38.00%
1-Day Range:
$1.20
$1.2499
1-Week Range:
$1.20
$1.34
52-Week Range:
$1.20
$16.63
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
1.24 | 2.42M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Painreform Ltd Stock (PRFX) Latest News
What drives PainReform Ltd stock pricePrice Support Zones & Double Digit Returns - earlytimes.in
Why PainReform Ltd. stock could rally in 20252025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - newser.com
Is PainReform Ltd. stock cheap at current valuation2025 Year in Review & Stock Portfolio Risk Control - newser.com
Best data tools to analyze PainReform Ltd. stock2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Price momentum metrics for PainReform Ltd. explainedMarket Movers & Accurate Buy Signal Notifications - newser.com
Will PainReform Ltd. bounce back from current support2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
How PainReform Ltd. stock compares to industry benchmarks2025 Price Action Summary & Step-by-Step Trade Execution Guides - newser.com
Regression analysis insights on PainReform Ltd. performanceTrade Ideas & Scalable Portfolio Growth Methods - newser.com
Is PainReform Ltd. stock attractive for long term wealth buildingEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Published on: 2025-10-28 00:12:36 - newser.com
Risk Analysis: Will PainReform Ltd. stock sustain high P E ratios2025 Year in Review & Growth Focused Entry Reports - Fundação Cultural do Pará
Published on: 2025-10-26 10:37:40 - newser.com
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):